| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 13 | +53.85% | +13.81% | -0.32% | +14.13% | +2.47% | — |
| 14d | 13 | +69.23% | +9.32% | +0.13% | +9.19% | +3.87% | — |
| 30d | 13 | +92.31% | +7.39% | +1.60% | +5.79% | +3.57% | — |
| 60d | 13 | +46.15% | -1.30% | +2.33% | -3.63% | -0.55% | — |
| 90d | 13 | +46.15% | +1.38% | +4.37% | -3.00% | -7.37% | — |
| 180d | 13(2 pending) | +0.00% | -34.60% | +4.02% | -38.62% | -42.18% | — |
| 1y | 13(4 pending) | +0.00% | -54.38% | +14.41% | -68.79% | -65.45% | — |
| 2y | 13(10 pending) | +0.00% | -86.74% | +30.39% | -117.13% | -117.13% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 80,700 | — | — | 80,700 | Mar 12, 2026 | Mar 16, 2026 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,175 | — | — | 393,895 | Mar 12, 2026 | Mar 16, 2026 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President/CEO | 28,100 | — | — | 28,100 | Jan 30, 2026 | Feb 2, 2026 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President/CEO | 28,100 | $0.89 | $25.0K | 373,720 | Jan 30, 2026 | Feb 2, 2026 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President/CEO | 21,459 | $1.17 | $25.0K | 21,459 | Dec 10, 2025 | Dec 11, 2025 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President/CEO | 21,459 | — | — | 21,459 | Dec 10, 2025 | Dec 11, 2025 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President/CEO | 3,003 | $1.87 | $5.6K | 343,123 | Apr 3, 2025 | Apr 4, 2025 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President/CEO | 2,497 | $1.80 | $4.5K | 345,620 | Apr 3, 2025 | Apr 4, 2025 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,725 | — | — | 340,120 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 26,900 | — | — | 26,900 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President/CEO | 500 | $3.92 | $2.0K | 333,395 | Oct 23, 2024 | Oct 24, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President/CEO | 250 | $2.90 | $725 | 332,895 | Oct 15, 2024 | Oct 16, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President/CEO | 1,000 | $2.59 | $2.6K | 332,645 | Oct 14, 2024 | Oct 15, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President/CEO | 150 | $2.54 | $381 | 331,645 | Oct 10, 2024 | Oct 15, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,725 | — | — | 331,495 | Mar 28, 2024 | Mar 28, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 26,900 | — | — | 26,900 | Mar 28, 2024 | Mar 28, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President, CEO | 2,000 | $7.29 | $14.6K | 324,770 | Mar 13, 2024 | Mar 14, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President, CEO | 1,000 | — | — | 1,000 | Mar 13, 2024 | Mar 14, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President, CEO | 1,000 | — | — | 1,000 | Mar 13, 2024 | Mar 14, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 4,000 | — | — | 322,770 | Mar 9, 2023 | Mar 13, 2023 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 16,000 | — | — | 16,000 | Mar 9, 2023 | Mar 13, 2023 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE President, CEO | 6,045,100 | — | — | 6,375,414 | Aug 23, 2022 | Mar 13, 2023 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | SALE President, CEO | 604,510 | — | — | 0 | Aug 23, 2022 | Mar 13, 2023 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 148,700 | — | — | 148,700 | Jul 28, 2022 | Aug 1, 2022 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 101,300 | — | — | 330,314 | Jul 28, 2022 | Aug 1, 2022 ↗ | View → |